| A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Alendronate in Healthy Adult Participants (MK-0616-027) | A Clinical Study to Evaluate the Effect of MK-0616 on the Pharmacokinetics of Alendronate in Healthy Adult Participants | NCT06772792 |
| Efficacy and Safety of Low-dose Ruxoltinib Combined with Thalidomide, Prednisone, and Testosterone Decanoate (TPT) in Patients with Lower and Intermediate Risk Myelofibrosis ---a Single Arm, Multicenter, and Prospective Study | Efficacy and Safety of Low-dose Ruxoltinib Combined with Thalidomide, Prednisone, and Testosterone Decanoate (TPT) in Patients with Lower and Intermediate Risk Myelofibrosis ---a Single Arm, Multicenter, and Prospective Study | ChiCTR2000035444 |
| A Study of Enlicitide Decanoate (MK-0616) and Semaglutide in Healthy Adult Participants (MK-0616-023) | A Clinical Study to Evaluate the Effect of MK-0616 and Semaglutide on Their Respective Pharmacokinetics in Healthy Adult Participants | NCT06699329 |
| A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss | A Randomized, Double-Blind, Placebo-Controlled, Phase I/II Trial of Nandrolone Decanoate in Women With HIV-Associated Weight Loss | NCT00000854 |
| Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective Disorder | Predicting the Optimal Pharmacotherapy for Outpatients With Schizophrenia | NCT00018642 |
| Fluphenazine Decanoate for Psoriasis | Ascending-Dose, Double-Blind, Placebo-Controlled, Bilateral Study of Intralesional Fluphenazine Decanoate in Psoriasis | NCT00356200 |
| A Randomized, Open-Label Study Comparing the Effectiveness of Olanzapine Pamoate Depot with Haloperidol Decanoate in the Treatment of Schizophrenia | A Randomized, Open-Label Study Comparing the Effectiveness of Olanzapine Pamoate Depot with Haloperidol Decanoate in the Treatment of Schizophrenia | EUCTR2007-003342-15-HU |
| Comparative pharmacokinetics and pharmcodynamics of recombinant and urinary human chorionic gonadotrophin (rhCG vs uhCG) | A two part study to compare the pharmacological effects of recombinant human chorionic gonadotrophin (rhCG/Ovidrel) versus urinary human chorionic gonadotrophin (uhCG/Pregnyl) given as subcutaneous injection to healthy men following supression of endogenous testosterone (T) and luteinising hormone (LH) with nandrolone decanoate(ND). | ACTRN12609000462280 |
| Lamictal TM, Haloperidol Decanoate in Schizophrenia | The Effect of Lamictal TM Augmentation of Haloperidol Decanoate in the Treatment of Resistant Schizophrenia Predominantly by Verbal Resistant Hallucinosis: Randomized, Double-blind, Placebo-controlled, Study | NCT00947375 |
| Nandrolone Decanoate in the Treatment of Telomeropathies | Male Hormones for Telomere Related Diseases | NCT02055456 |
| A study to assess the efficacy and safety of Nandrolone decanoate and alendronate as compared to alendronate alone in patients with disease in which bones are very fragile | An academic clinical study to assess the efficacy and safety of Nandrolone decanoate and alendronate as compared to alendronate alone in patients with Osteoporosis | CTRI/2019/08/020843 |
| Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Renal Impairment Study (MK-0616-020) | An Open-Label, Single-Dose Clinical Study to Evaluate the Pharmacokinetics of MK-0616 in Participants With Varying Degrees of Renal Impairment | NCT05934292 |
| The effect of leucine and nandrolone decanoate supplementation on muscle loss during immobilisation | The effect of leucine and nandrolone decanoate supplementation on muscle loss during immobilisation - nandrolone and leucine during immobilisation | NL-OMON41995 |
| The Effect of Food and Water Volume in Healthy Adult Participants Administered Enlicitide Decanoate (MK-0616) (MK-0616-022) | A Clinical Study to Evaluate the Effect of Food and Water Volume on the Pharmacokinetics of the MK-0616 Final Market Formulation in Healthy Adult Participants | NCT06658652 |
| A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-0616 in Adults With Hypercholesterolemia | NCT05952856 |
| A Study of Enlicitide Decanoate (MK-0616), Warfarin, and Lisinopril in Healthy Adult Participants (MK-0616-026) | A Clinical Study to Evaluate the Effect of MK-0616 on Warfarin and Lisinopril Pharmacokinetics in Healthy Adult Participants | NCT06772779 |
| "The IM-ZBULLE Study : "" Z-track "" and "" Airlock "" Techniques During Intramuscular Injection of Haloperidol Decanoate" | "Efficacy of the Combination of "" Z-track "" and "" Airlock "" Techniques During Intramuscular Injection of Haloperidol Decanoate in Adult Patients With Schizophrenic or Related Disorder : A Multicenter Randomized Controlled Trial" | NCT05995457 |
| Study of the Effectiveness of Treatment of Sarcopenia With the Use of a Medicinal Product (Nandrolone), Comprehensive Physiotherapy and Diet | Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Nandrolone Decanoate Therapy and Therapy With Complex Physiotherapy and Diet in the Treatment of Sarcopenia | NCT05978206 |
| Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes | Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascular Events in Participants at High Cardiovascular Risk | NCT06008756 |
| A Study to Evaluate the Efficacy and Safety of Enlicitide Decanoate (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018) CORALreef AddOn | A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of MK-0616 Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia | NCT06450366 |
| A Study of Levothyroxine and Enlicitide Decanoate (MK-0616) in Healthy Adult Participants (MK-0616-028) | A Clinical Study to Evaluate the Effect of MK-0616 on the Pharmacokinetics of Levothyroxine in Healthy Adult Participants | NCT06625814 |
| A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Atorvastatin in Healthy Adult Participants (MK-0616-024) | A Clinical Study to Evaluate the Effect of MK-0616 and Atorvastatin on Their Respective Pharmacokinetics in Healthy Adult Participants | NCT06699355 |
| A Clinical Study of Enlicitide Decanoate (MK-0616) in Healthy Adult Participants (MK-0616-025) | A Clinical Study to Evaluate the Relative Bioavailability of MK-0616 Formulations in Healthy Adult Participants | NCT06691906 |
